Indicators

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says

August 16, 2023

Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion

August 10, 2023

Wegovy-maker Novo Nordisk sales soar 30% on strong demand for its weight-loss drug

August 10, 2023

Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data

August 09, 2023

Obesity drug Wegovy's landmark trial result could 'open up' health insurance access, analyst says

August 09, 2023

Stocks making the biggest moves midday: Beyond Meat, Chegg, PNC Financial, Dish & more

August 08, 2023

Stocks making the biggest moves premarket: UPS, Lucid, Beyond Meat, Novo Nordisk and more

August 08, 2023

Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials

July 27, 2023

UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks

July 26, 2023

Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait

July 26, 2023

Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion

July 14, 2023

Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says

July 13, 2023

EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs

July 11, 2023

Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all

July 11, 2023

Stocks making the biggest moves midday: Shutterstock, Newell Brands, Zillow and more

July 11, 2023

European regulator to review weight-loss drugs following reports of suicidal thoughts

July 10, 2023

Moderna strikes deal to develop mRNA drugs in China

July 05, 2023

People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says

June 30, 2023

As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge

June 28, 2023

Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says

June 26, 2023

Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss

June 26, 2023

Pfizer to end development of experimental obesity pill due to elevated liver enzymes

June 26, 2023

Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy

June 20, 2023

Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says

May 22, 2023

Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge

May 10, 2023

Novo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars

May 04, 2023

Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow

April 28, 2023

Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds

April 27, 2023

Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices

April 21, 2023

Senate legislation would cap insulin at $35 per month for people with private insurance

April 21, 2023

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.